BioSpace News Archive

RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announces today completion of its $2.35 million seed round financing from multiple venture capitalists including Terra Magnum Capital Partners. The Company will use the proceeds to advance its Covid-19

Chiesi USA, a specialty pharmaceutical company based in Cary, North Carolina, was named Company of the Year by the Triangle Business Journal 2020 Life Sciences Awards in honor of its noteworthy work in the life sciences industry.

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today provided additional information about its upcoming virtual 2019 Annual Meeting of Shareholders (“Annual Meeting”).

Medial EarlySign (earlysign.com), a leader in AI-based clinical data solutions to aid in the early detection and prevention of high-burden diseases, announced today that Barts Health, one of the largest National Health Service providers in Britain, has implemented EarlySign’s ColonFlag™ platform to prioritize and care for patients at high risk for developing colon cancer.

Eurofins Discovery is expanding its footprint to serve the growing market of outsourced drug discovery with its high-quality chemistry capabilities

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Nedal Safwat has been appointed Chief Strategy Officer

A recent survey, conducted by The Harris Poll on behalf of GSK, finds that many adults ages 50-79 are unfamiliar with the vaccines recommended for them.

The Medical Device Innovation Consortium (MDIC) has announced the release of its Real-World Evidence Framework for regulatory decision-making for in vitro diagnostics (IVDs). Created through a collaborative process between MDIC, FDA CDRH, and industry partners, the framework aims to help industry and FDA consider when and how real-world data might be incorporated into product development and regulatory decision-making i

PPD, Inc., a leading global contract research organization, has been named to Forbes magazine’s 2020 list of America’s Best-in-State Employers for North Carolina.

Valencia Technologies Corporation (“Valencia”), a private medical device company, today announced the filing of its pre-market approval (PMA) application of its eCoin® Peripheral Neurostimulator System for overactive bladder with the Food and Drug Administration (FDA).